ID28967A - Benzisoksazol dan fenon sebagai alfa 2-antagonis - Google Patents

Benzisoksazol dan fenon sebagai alfa 2-antagonis

Info

Publication number
ID28967A
ID28967A IDW00200101335A ID20011335A ID28967A ID 28967 A ID28967 A ID 28967A ID W00200101335 A IDW00200101335 A ID W00200101335A ID 20011335 A ID20011335 A ID 20011335A ID 28967 A ID28967 A ID 28967A
Authority
ID
Indonesia
Prior art keywords
benzisoksazol
antagonis
phenon
alfa
Prior art date
Application number
IDW00200101335A
Other languages
English (en)
Indonesian (id)
Inventor
Ludo E J Kennis
J C Mertens
S M A Pieters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID28967A publication Critical patent/ID28967A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IDW00200101335A 1998-12-21 1999-12-14 Benzisoksazol dan fenon sebagai alfa 2-antagonis ID28967A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98204358 1998-12-21

Publications (1)

Publication Number Publication Date
ID28967A true ID28967A (id) 2001-07-19

Family

ID=8234508

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101335A ID28967A (id) 1998-12-21 1999-12-14 Benzisoksazol dan fenon sebagai alfa 2-antagonis

Country Status (30)

Country Link
US (1) US6576640B1 (xx)
EP (1) EP1140934B1 (xx)
JP (1) JP4717216B2 (xx)
KR (2) KR100657540B1 (xx)
CN (1) CN1154646C (xx)
AR (1) AR021924A1 (xx)
AT (1) ATE251622T1 (xx)
AU (1) AU765751B2 (xx)
BG (1) BG65162B1 (xx)
BR (1) BR9916427A (xx)
CA (1) CA2355716C (xx)
CZ (1) CZ294532B6 (xx)
DE (1) DE69911995T2 (xx)
EA (1) EA003606B1 (xx)
EE (1) EE200100329A (xx)
ES (1) ES2209553T3 (xx)
HK (1) HK1045686B (xx)
HR (1) HRP20010444A2 (xx)
HU (1) HUP0104812A3 (xx)
ID (1) ID28967A (xx)
IL (2) IL143830A0 (xx)
NO (1) NO317892B1 (xx)
NZ (1) NZ511411A (xx)
PL (1) PL196958B1 (xx)
SK (1) SK285560B6 (xx)
TR (1) TR200101813T2 (xx)
TW (1) TWI229673B (xx)
UA (1) UA71938C2 (xx)
WO (1) WO2000037466A1 (xx)
ZA (1) ZA200105067B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2451606A1 (en) 2001-07-05 2003-01-16 Pharmacia & Upjohn Company (hetero) aryl substituted benzofurans as 5-ht ligands
CA2480266C (en) * 2002-04-03 2011-07-12 Orion Corporation Use of an alpha2-adrenoreceptor antagonist for cns-related diseases
CN1972938B (zh) 2004-04-12 2010-09-29 大正制药株式会社 环状胺化合物
JP2009502959A (ja) * 2005-07-28 2009-01-29 ブリストル−マイヤーズ スクイブ カンパニー セロトニン受容体アゴニストおよびアンタゴニストとしての置換テトラヒドロ−１ｈ−ピリド［４，３，ｂ］インドール

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3419568A (en) * 1966-12-07 1968-12-31 Abbott Lab Derivatives of 1,2,3,4-tetrahydro-5h-pyrido[4,3b]indoles
US3718657A (en) * 1970-12-03 1973-02-27 Abbott Lab Certain-2-substituted-1,2,3,4-tetrahydro-beta or gamma carbolines
JPS4729395U (xx) * 1971-04-26 1972-12-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
AR207799A1 (es) * 1974-04-01 1976-10-29 Pfizer Procedimiento para preparar azaciclo(3,4-a)-n-fenilindoles-2-substituidos
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4985422A (en) 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
WO1994008040A1 (en) * 1992-09-25 1994-04-14 Synaptic Pharmaceutical Corporation Dna encoding human alpha 1 adrenergic receptors and uses thereof
US5508306A (en) * 1992-11-13 1996-04-16 Synaptic Pharmaceutical Corporation Aromatic amine derivatives
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

Also Published As

Publication number Publication date
TR200101813T2 (tr) 2001-12-21
JP4717216B2 (ja) 2011-07-06
AR021924A1 (es) 2002-09-04
CA2355716C (en) 2010-05-18
WO2000037466A1 (en) 2000-06-29
EP1140934A1 (en) 2001-10-10
BG105521A (en) 2001-12-29
KR20010075650A (ko) 2001-08-09
TWI229673B (en) 2005-03-21
DE69911995D1 (de) 2003-11-13
EA003606B1 (ru) 2003-06-26
ATE251622T1 (de) 2003-10-15
NZ511411A (en) 2002-12-20
HK1045686A1 (en) 2002-12-06
EA200100709A1 (ru) 2001-12-24
NO20012783L (no) 2001-06-06
IL143830A (en) 2007-07-24
HUP0104812A3 (en) 2003-12-29
DE69911995T2 (de) 2004-09-02
CZ294532B6 (cs) 2005-01-12
CN1331692A (zh) 2002-01-16
IL143830A0 (en) 2002-04-21
ES2209553T3 (es) 2004-06-16
CZ20012120A3 (cs) 2001-10-17
SK8582001A3 (en) 2001-12-03
NO20012783D0 (no) 2001-06-06
ZA200105067B (en) 2002-06-20
JP2002533341A (ja) 2002-10-08
BR9916427A (pt) 2001-09-04
UA71938C2 (en) 2005-01-17
HUP0104812A2 (hu) 2002-04-29
AU765751B2 (en) 2003-09-25
KR20060093139A (ko) 2006-08-23
CA2355716A1 (en) 2000-06-29
AU2432700A (en) 2000-07-12
SK285560B6 (sk) 2007-03-01
CN1154646C (zh) 2004-06-23
NO317892B1 (no) 2004-12-27
HRP20010444A2 (en) 2002-06-30
US6576640B1 (en) 2003-06-10
PL348421A1 (en) 2002-05-20
BG65162B1 (bg) 2007-04-30
PL196958B1 (pl) 2008-02-29
KR100657540B1 (ko) 2006-12-14
EP1140934B1 (en) 2003-10-08
EE200100329A (et) 2002-08-15
HK1045686B (zh) 2005-04-01

Similar Documents

Publication Publication Date Title
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID22957A (id) Senyawa dan penggunaannya
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID24148A (id) Turunan-turunan fitostfrol dan/atau fitostanol
ID28990A (id) Herbisida-herbisida dengan urea aminofenilsulfonil asilasi
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
DE69816798D1 (de) Wiederverschliessbarer verschluss
BR9801675A (pt) Vedação
ID24196A (id) Komposisi dan penggunaan
ID23173A (id) Turunan pirol trisiklik atau pirazol
ID26599A (id) Turunan triazola dan imidazola
ID26156A (id) Benzotiadiazol dan turunan-turunan
DE69808924T2 (de) Dichtung
DE69905366T2 (de) Dichtung
DE69832237D1 (de) Abdichtung
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID29052A (id) Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina
ID23258A (id) Penarik pemberian-menyilang dan metodenya
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
DE69913880D1 (de) Dichtung
BRPI9816175B1 (pt) Gaxeta
DE69915946D1 (de) Dichtung
ID28967A (id) Benzisoksazol dan fenon sebagai alfa 2-antagonis